Home > Documents in Process > Portable ultra-low-field MRI in acute stroke care: A pilot study. > print

001     282587
005     20251209092645.0
024 7 _ |a 10.1177/23969873251344761
|2 doi
024 7 _ |a pmid:40515383
|2 pmid
024 7 _ |a pmc:PMC12170540
|2 pmc
024 7 _ |a 2396-9873
|2 ISSN
024 7 _ |a 2396-9881
|2 ISSN
037 _ _ |a DZNE-2025-01347
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a von Danwitz, Niklas M
|0 P:(DE-2719)9002283
|b 0
|e First author
245 _ _ |a Portable ultra-low-field MRI in acute stroke care: A pilot study.
260 _ _ |a London
|c 2025
|b Sage Publishing
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1765268592_7325
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Neuroimaging is a prerequisite for treatment of stroke patients, but it is not available all over the globe. Portable ultra-low field (pULF) MRI has the potential to improve access to neuroimaging and thus stroke care worldwide. In a pilot study, we were the first to utilise pULF-MRI in a European tertiary stroke centre and to evaluate its diagnostic value compared to high-field (HF) MRI.Consecutive patients admitted for suspected ischaemic stroke underwent pULF-MRI using the 0.064 Tesla Swoop® portable MR imaging system in addition to standard imaging. HF-MRI and pULF-MRI scans were blindly assessed to compare the diagnostic accuracy and imaging-based therapeutic decisions based on pULF-MRI to HF-MRI.Seventeen patients underwent pULF-MRI, 12 of whom had ischaemic lesions on HF-MRI. Ischaemic lesions were detected on pULF-MRI in 8/12 cases. The four infarcts not identified on pULF-MRI were all smaller than 6 mm in diameter. In all cases, a virtual treatment decision based on pULF-MRI by a blinded team matched the actual clinical decisions.This single-centre study demonstrates that pULF-MRI is a promising tool in acute stroke care, providing reliable imaging for treatment decision and follow-up monitoring. pULF-MRI may support acute stroke care if HF-MRI is unavailable and may be particularly helpful in resource-limited settings. Limitations of pULF-MRI include long acquisition times and the lack of vessel imaging and haemorrhage-sensitive sequences.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 1
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 2
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Stroke
|2 Other
650 _ 7 |a acute care
|2 Other
650 _ 7 |a emergency department
|2 Other
650 _ 7 |a health equality
|2 Other
650 _ 7 |a point of care imaging
|2 Other
650 _ 7 |a portable ultra-low-field MRI
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Pilot Projects
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging: methods
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging: instrumentation
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Stroke: diagnostic imaging
|2 MeSH
650 _ 2 |a Ischemic Stroke: diagnostic imaging
|2 MeSH
650 _ 2 |a Neuroimaging: methods
|2 MeSH
650 _ 2 |a Neuroimaging: instrumentation
|2 MeSH
700 1 _ |a Lehnen, Nils C
|b 1
700 1 _ |a Meißner, Julius N
|0 0000-0002-8980-9337
|b 2
700 1 _ |a Samani, Omid Shirvani
|0 P:(DE-2719)9002936
|b 3
700 1 _ |a Asperger, Hannah
|0 P:(DE-2719)9003181
|b 4
|u dzne
700 1 _ |a Thielscher, Christian
|0 P:(DE-2719)9002386
|b 5
|u dzne
700 1 _ |a Ebrahimi, Taraneh
|0 P:(DE-2719)9003076
|b 6
700 1 _ |a Layer, Julia
|0 0000-0001-5904-5316
|b 7
700 1 _ |a Nitsch, Louisa
|b 8
700 1 _ |a Dorn, Franziska
|b 9
700 1 _ |a Radbruch, Alexander
|0 P:(DE-2719)9001861
|b 10
|u dzne
700 1 _ |a Bode, Felix J
|0 P:(DE-2719)2811949
|b 11
700 1 _ |a Weller, Johannes M
|0 0000-0001-5818-5392
|b 12
700 1 _ |a Groteklaes, Anne
|b 13
700 1 _ |a Petzold, Gabor C
|0 P:(DE-2719)2810273
|b 14
|u dzne
700 1 _ |a Sabir, Hemmen
|0 P:(DE-2719)9000732
|b 15
|u dzne
700 1 _ |a Stösser, Sebastian
|0 P:(DE-2719)9000778
|b 16
|u dzne
773 _ _ |a 10.1177/23969873251344761
|g Vol. 10, no. 4, p. 1430 - 1437
|0 PERI:(DE-600)2851287-X
|n 4
|p 1430 - 1437
|t European stroke journal
|v 10
|y 2025
|x 2396-9873
856 4 _ |u https://pub.dzne.de/record/282587/files/DZNE-2025-01347_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/282587/files/DZNE-2025-01347_Restricted.pdf?subformat=pdfa
|x pdfa
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9002283
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9002936
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9003181
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9002386
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9003076
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 0000-0001-5904-5316
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)9001861
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 11
|6 P:(DE-2719)2811949
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2810273
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)9000732
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 1
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 2
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2024-12-28
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR STROKE J : 2022
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-28
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR STROKE J : 2022
|d 2024-12-28
920 1 _ |0 I:(DE-2719)1011401
|k Clinical Research Platform (CRP)
|l Clinical Research Platform (CRP)
|x 0
920 1 _ |0 I:(DE-2719)1013020
|k AG Petzold
|l Vascular Neurology
|x 1
920 1 _ |0 I:(DE-2719)1013038
|k AG Schultze
|l Clinical Single Cell Omics (CSCO) / Systems Medicine
|x 2
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies (Bonn)
|l Patient Studies (Bonn)
|x 3
920 1 _ |0 I:(DE-2719)5000075
|k AG Radbruch
|l Clinical Neuroimaging
|x 4
920 1 _ |0 I:(DE-2719)5000032
|k AG Sabir
|l Neonatal Neuroscience
|x 5
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1011401
980 _ _ |a I:(DE-2719)1013020
980 _ _ |a I:(DE-2719)1013038
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)5000075
980 _ _ |a I:(DE-2719)5000032
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21